HELP Earnings Date: Nov 12, 2026 (Estimated) — Helus Pharma Inc.
NASDAQ · Healthcare · Biotechnology
Updated
When is HELP's next earnings date?
Helus Pharma Inc. (HELP) is expected to report Q2 2026 earnings on Thursday, November 12, 2026 at 7:00 AM ET (before market open); the date is an estimate and has not been confirmed by the company. The consensus estimate is EPS of -$0.67.
How did HELP do in its last earnings report?
In its most recent report on Aug 14, 2026 (Q1 2026), Helus Pharma Inc. posted EPS of -$0.91 versus the -$0.84 estimate, a miss of 14.9%. Revenue was $0. The stock's 1-day post-earnings move was +4.7%.
How much does HELP stock move after earnings?
HELP beat EPS estimates in 1 of its last 3 reported quarters. Over the last 3 reports the stock moved an average of 4.6% (up or down) in the day after earnings.
About Helus Pharma Inc.
Helus Pharma is a clinical-stage pharmaceutical company developing proprietary serotonergic agonists for mental health conditions. Its pipeline includes HLP003, in Phase 3 development for adjunctive treatment of major depressive disorder, and HLP004, in Phase 2 development for generalized anxiety disorder.
Earnings History
| Date | Period | EPS Est. | EPS Act. | Surprise | Revenue | Result | 1D Δ | 1W Δ | 1M Δ |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-14 | Q1 2026 | -0.84 | -0.91 | +14.95% | $0 | ❌ Miss | +4.72% | +9.00% | +18.86% |
| 2026-06-29 | Q4 2025 | -1.11 | -0.85 | +23.42% | $0 | ✅ Beat | +6.17% | -9.10% | +17.28% |
| 2026-02-13 | Q3 2025 | -0.80 | -1.00 | -25.00% | $0 | ❌ Miss | +2.87% | +15.03% | -20.78% |
| 2022-11-14 | — | -0.06 | — | — | — | — | — | — | |
| 2022-08-08 | — | -0.07 | — | — | — | — | — | — | |
| 2022-03-31 | — | -0.10 | — | — | — | — | — | — | |
| 2022-02-10 | — | -0.10 | — | — | — | — | — | — | |
| 2021-11-15 | — | -0.11 | — | — | — | — | — | — |
Showing last 8 quarters.